Repeated daily exposure to 2 ppm nitrogen dioxide upregulates the expression of IL-5, IL-10, IL-13, and ICAM-1 in the bronchial epithelium of healthy human airways

Occupational and Environmental Medicine

Volumn 60, Issue 11, 2003, Pages 892-896

  Pathmanathan, S ^a   Krishna, M T ^a   Blomberg, A ^b   Helleday, R ^b   Kelly, F J ^c   Sandstrom T ^b   Holgate, S T ^a   Wilson, S J ^a   Frew, A J ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UMEÅ UNIVERSITY   (Sweden)

^c ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 5; NITROGEN DIOXIDE;

ADULT; ARTICLE; BRONCHUS BIOPSY; BRONCHUS MUCOSA; DISEASE PREDISPOSITION; ENVIRONMENTAL EXPOSURE; FEMALE; FIBEROPTIC BRONCHOSCOPY; HUMAN; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MALE; NEUTROPHIL CHEMOTAXIS; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; RHINOVIRUS; UPREGULATION;

ADULT; AIR POLLUTANTS; BRONCHI; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOENZYME TECHNIQUES; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-10; INTERLEUKIN-13; INTERLEUKIN-5; INTERLEUKINS; MALE; NITROGEN DIOXIDE; OBSERVER VARIATION; RESPIRATORY MUCOSA; UP-REGULATION;

BRONCHUS; PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS; RHINOVIRUS;

EID: 0242266454     PISSN: 13510711     EISSN: None     Source Type: Journal    
DOI: 10.1136/oem.60.11.892     Document Type: Article

References (30)

1. Department of Health, Committee on the Medical Aspects of Air Pollutants. Asthma and outdoor pollution. London: HMSO, 1995.
2. Melia RJ, Florey CD, Altman DG, et al. Association between gas cooking and respiratory disease in children. BMJ 1977;2:149-52.
3. Melia RJ, Florey CV, Chinn S. The relation between respiratory illness in primary school children and the use of gas for cooking - I. Results from a national survey. Int J Epidemiol 1979;8:333-8.
4. Gardner DE. Oxidant-induced enhanced sensitivity to infection in animal models and their extrapolation to man. J Toxicol Environ Health 1984;13:423-39.
5. 2 on the airways of healthy subjects. Am J Respir Crit Care Med 1997;157(2 pt 1):418-24.
6. Blomberg A, Krishna MT, Helleday R, et al. Persistent airway inflammation but accommodated antioxidant and lung function responses after repeated daily exposure to nitrogen dioxide. Am J Respir Crit Care Med 1999;159:536-43.
7. Mustafa MG, Tierney DF. Biochemical and metabolic changes in the lung with oxygen, ozone and nitrogen dioxide toxicity. Am Rev Respir Dis 1978;118:1061-90.
8. Devalia JL, Sapsford RJ, Cundell DR, et al. Human bronchial epithelial cell dysfunction following in vitro exposure to nitrogen dioxide. Eur Respir J 1993;6:1308-16.
9. Devalia JL, Campbell AM, Sapsford RJ, et al. The effect of nitrogen dioxide on synthesis of inflammatory cytokines expressed by human bronchial epithelial cells in vitro. Am J Respir Cell Mol Biol 1993;9:271-8.
10. Davies RJ, Bayram H, Khair DA, et al. Loratidine attenuates nitrogen dioxide induced release of proinflammatory mediators from human bronchial epithelial cells in vitro. J Allergy Clin Immunol 1997;99(1 pt 2):673.
11. Britten KM, Howarth PH, Roche WR. Immunohistochemistry on resin sections: a comparison of resin embedding techniques for small mucosal biopsies. Biotech Histochem 1993;68:271-80.
12. Salvi SS, Semper A, Blomberg A, et al. Interleukin-5 production by human airways epithelial cells. Am J Respir Cell Mol Biol 1999;20:984-91.
13. Shi HZ, Li CQ, Qin SM, et al. Effect of inhaled IL-5 on the number and activity of eosinophils in circulation from asthmatics. Clin Immunol 1999;103:463-7.
14. Shardonofsky FR, Venzor J III, Barrios R, et al. Therapeutic efficacy of an anti-IL-5 monoclonal antibody delivered into the respiratory tract in a murine model of asthma. J Allergy Clin Immunol 1999;104:215-21.
15. Hammelman E, Gelfand EW. Role of IL-5 in the development of allergen-induced airway hyperresponsiveness. Int Arch Allergy Immunol 1999;120:8-16.
16. Zhu Z, Homer RJ, Wang Z, et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiological abnormalities, and eotaxin production. J Clin Invest 1999;103:779-88.
17. Van der Pouw Kraan TC, Van der Zee JS, Boeije LC, et al. The role of IL-13 in IgE synthesis by allergic asthma patients. Clin Exp Immunol 1998;111:129-35.
18. Humbert M, Durham SR, Kimmitt P, et al. Elevated expression of messenger ribonucleic acid encoding IL-13 in the bronchial mucosa of atopic and non-atopic subjects with asthma. J Allergy Clin Immunol 1997;99:657-65.
19. Van Scott MR, Justice JP, Bradfield JF, et al. IL-10 reduces Th2 cytokine production and eosinophilia but augments airway reactivity in allergic mice. Am J Physiol Lung Cell Mol Physiol 2000;278:L667-74.
20. Cassatella MA, Meda L, Bonora S, et al. Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysaccharide. J Exp Med 1993;178:2207-11.
21. Fiorentine DF, Zlotnik A, Mosmann TR, et al. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991;147:3815-22.
22. Bonfield TL, Konstan MW, Burfeind P, et al. Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis. Am J Respir Cell Mol Biol 1995;13:257-61.
23. Takanashi S, Hasegawa Y, Kanehira Y, et al. Interleukin-10 level in sputum is reduced in bronchial asthma, COPD and in smokers. Eur Respir J 1999;14:309-14.
24. Montefort S, Holgate ST, Howarth PH. Leucocyte-endothelial adhesion molecules and their role in bronchial asthma and allergic rhinitis. Eur Respir J 1993;6:1044-54.
25. Greve JM, Davis G, Meyer AM, et al. The major human rhinovirus receptor is ICAM-1. Cell 1989;56:839-47.
26. Staunton DE, Merluzzi VJ, Rothlein R, et al. A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses. Cell 1989;56:849-53.
27. Krutmann J, Kock A, Schauer E, et al. Tumour necrosis factor beta and ultraviolet radiation are potent regulators of human keratinocyte ICAM-1 expression. J Invest Dermatol 1990;95:127-31.
28. Matsuzki Z, Okamoto Y, Sarashina N, et al. Induction of intracellular adhesion molecule-1 in human nasal epithelial cells during respiratory syncytial virus infection. Immunology 1996;88:565-8.
29. 2) and the risk of virus related asthma morbidity in children [abstract]. Am J Respir Crit Care Med 1999;159:A699.
30. Bianco A, Sethi SK, Allen JT, et al. Th2 cytokines exert a dominant influence on epithelial cell expression of the major group human rhinovirus receptor, ICAM-1. Eur Respir J 1998;12:619-26.